Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 315.79 million compared to CNY 191.02 million a year ago. Revenue was CNY 315.79 million compared to CNY 191.02 million a year ago. Net income was CNY 347.45 million compared to net loss of CNY 105.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.5267 compared to basic loss per share from continuing operations of CNY 0.1607 a year ago. Diluted earnings per share from continuing operations was CNY 0.5267 compared to diluted loss per share from continuing operations of CNY 0.1607 a year ago.